Related Experiment Video
Updated: Jul 14, 2026

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
Published on: July 11, 2015
Next generation: tuberculosis vaccines that elicit protective CD8+ T cells
Samuel M Behar1, Joshua S M Woodworth, Ying Wu
1Brigham and Women's Hospital and Harvard Medical School, Division of Rheumatology, Immunology and Allergy, Smith Building, Room 516C, One Jimmy Fund Way, Boston, MA 02115, USA. sbehar@rics.bwh.harvard.edu
Developing a tuberculosis vaccine is crucial due to drug resistance and HIV coinfection. This review highlights the importance of CD8+ T cells and suggests vaccines eliciting both CD4+ and CD8+ T cells offer the best protection against tuberculosis.
Area of Science:
- Immunology
- Vaccinology
- Infectious Diseases
Background:
- Tuberculosis (TB) remains a significant global health burden, causing widespread illness and death.
- Multidrug resistance in TB complicates treatment, increasing the urgency for effective interventions.
- HIV coinfection exacerbates TB morbidity and mortality, underscoring the need for improved control strategies.
Purpose of the Study:
- To review the role of CD8+ T cells in tuberculosis immunity.
- To explore vaccination strategies for eliciting protective CD8+ T cell responses.
- To assess the potential of CD8+ T cells in a future TB vaccine.
Main Methods:
- Literature review of studies on CD8+ T cell function in tuberculosis.
- Analysis of data on various immunization strategies targeting CD8+ T cells.
- Evaluation of evidence for vaccine-induced CD8+ T cell-mediated protection.
Main Results:
- CD8+ T cells play a critical role in cellular immunity against tuberculosis.
- Multiple vaccination approaches show potential for inducing CD8+ T cell responses.
- Synergy exists between CD4+ and CD8+ T cell responses in conferring protection.
Conclusions:
- Vaccine-induced CD8+ T cells are a promising avenue for tuberculosis prevention.
- A comprehensive TB vaccine should aim to elicit both CD4+ and CD8+ T cell immunity.
- Targeting both T cell subsets may provide the most effective strategy against tuberculosis.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis

